Inventor
HOSAKA EMI
JP39 patents
⚠️ This page may combine multiple inventors who share the name “HOSAKA EMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYOWA HAKKO KIRIN CO LTD
23 patentsUS7737325B2Jun 15, 2010
Antibody composition-producing cell
KYOWA HAKKO KIRIN CO LTD55 citations99
US7708992B2May 4, 2010
Methods for producing antibody compositions with increased ADCC
KYOWA HAKKO KIRIN CO LTD51 citations98
US7651688B2Jan 26, 2010
Method of modulating the activity of functional immune molecules to CD52
KYOWA HAKKO KIRIN CO LTD47 citations98
US7846725B2Dec 7, 2010
Antibody composition-producing cell in which enzyme expression is inhibited by RNAi
KYOWA HAKKO KIRIN CO LTD35 citations96
US7763246B2Jul 27, 2010
Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor
KYOWA HAKKO KIRIN CO LTD23 citations96
US7741442B2Jun 22, 2010
Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation
KYOWA HAKKO KIRIN CO LTD32 citations96
US7718175B2May 18, 2010
Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein
KYOWA HAKKO KIRIN CO LTD32 citations96
US7708997B2May 4, 2010
Method of modulating the activity of functional immune molecules
KYOWA HAKKO KIRIN CO LTD24 citations96
US7687061B2Mar 30, 2010
Method of modulating the activity of functional immune molecules to Her-2
KYOWA HAKKO KIRIN CO LTD29 citations96
US7682610B2Mar 23, 2010
Method of modulating the activity of functional immune molecules
KYOWA HAKKO KIRIN CO LTD33 citations96
US7682611B2Mar 23, 2010
Method of modulating the activity of functional immune molecules to CXCR4 protein
KYOWA HAKKO KIRIN CO LTD26 citations96
US7655228B2Feb 2, 2010
Method of modulating the activity of functional immune molecules to GM2
KYOWA HAKKO KIRIN CO LTD24 citations96
US8039595B2Oct 18, 2011
Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation
KYOWA HAKKO KIRIN CO LTD9 citations93
US7842797B2Nov 30, 2010
Human CDR-grafted antibody and antibody fragment thereof
KYOWA HAKKO KIRIN CO LTD14 citations92
US10233247B2Mar 19, 2019
Method of modulating the activity of functional immune molecules
KYOWA HAKKO KIRIN CO LTD2 citations84
US8895266B2Nov 25, 2014
Antibody composition-producing cell
KYOWA HAKKO KIRIN CO LTD4 citations84
US10233475B2Mar 19, 2019
Antibody composition-producing cell
KYOWA HAKKO KIRIN CO LTD0 citations63
US9409982B2Aug 9, 2016
Antibody composition-producing cell
KYOWA HAKKO KIRIN CO LTD0 citations63
US8367407B2Feb 5, 2013
Cells with altered fucosylation and producing antibodies therefrom
KYOWA HAKKO KIRIN CO LTD0 citations63
US10590203B2Mar 17, 2020
Human CDR-grafted antibody and antibody fragment thereof
KYOWA HAKKO KIRIN CO LTD0 citations52
US10131711B2Nov 20, 2018
Human CDR-grafted antibody and antibody fragment thereof
KYOWA HAKKO KIRIN CO LTD0 citations52
US9051371B2Jun 9, 2015
Human CDR-grafted antibody and antibody fragment thereof
KYOWA HAKKO KIRIN CO LTD0 citations52
US8900584B2Dec 2, 2014
Human CDR-grafted antibody and antibody fragment thereof
KYOWA HAKKO KIRIN CO LTD0 citations52
KYOWA HAKKO KOGYO KK
7 patentsUS7425446B2Sep 16, 2008
Antibody composition-producing cell
KYOWA HAKKO KOGYO KK93 citations99
US7393683B2Jul 1, 2008
Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase
KYOWA HAKKO KOGYO KK63 citations99
US7214775B2May 8, 2007
Method of modulating the activity of functional immune molecules
KYOWA HAKKO KOGYO KK363 citations99
US6946292B2Sep 20, 2005
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
KYOWA HAKKO KOGYO KK566 citations99
US7064191B2Jun 20, 2006
Process for purifying antibody
KYOWA HAKKO KOGYO KK89 citations98
US7504104B2Mar 17, 2009
Human CDR-grafted antibody and antibody fragment thereof
KYOWA HAKKO KOGYO KK28 citations96
US7404953B2Jul 29, 2008
Methods using eosinophil-specific apoptosis inducer
KYOWA HAKKO KOGYO KK6 citations74
KANDA YUTAKA
5 patentsUS8067232B2Nov 29, 2011
Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase
KANDA YUTAKA45 citations97
US8101185B2Jan 24, 2012
Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation
KANDA YUTAKA6 citations92
US8329443B2Dec 11, 2012
Antibody composition-producing cell
KANDA YUTAKA4 citations73
US8158760B2Apr 17, 2012
Glycoengineered, recombinant antibody
KANDA YUTAKA4 citations73
US8110195B2Feb 7, 2012
Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody
KANDA YUTAKA4 citations73